Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian R Curtis

Showing results (91-100 of 107) with videos related to

Pageof 11
Sort By:
Chest|February 25, 2016
A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/ThrombosisAnand Padmanabhan, Curtis G Jones, Brian R Curtis, et al.
Thrombosis and Haemostasis|January 17, 2003
Acute thrombocytopenia in patients treated with the oral glycoprotein IIb/IIIa inhibitors xemilofiban and orbofiban: evidence for an immune etiologyJacqueline A Brassard, Brian R Curtis, Richard A Cooper, et al.
Blood|February 15, 2018
Patients treated with oxaliplatin are at risk for thrombocytopenia caused by multiple drug-dependent antibodiesBrian R Curtis, Yen-Michael S Hsu, Nikolai Podoltsev, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|January 18, 2020
Strategies to develop a prophylaxis for the prevention of HPA-1a immunization and fetal and neonatal alloimmune thrombocytopeniaMette Kjær, Christof Geisen, Çiğdem Akalın Akkök, et al.
Blood|May 20, 2004
Anti-GPVI-associated ITP: an acquired platelet disorder caused by autoantibody-mediated clearance of the GPVI/FcRgamma-chain complex from the human platelet surfaceBrian Boylan, Hong Chen, Vipul Rathore, et al.
JCO Oncology Practice|December 3, 2020
Trastuzumab-Induced Thrombocytopenia Correlated by Drug-Dependent Platelet AntibodiesKathleen Sullivan, Lynne S Kaminer, David L Grinblatt, et al.
Blood|April 21, 2026
PF4/Heparin-Nonbinding Platelet-Activating Antibodies in Heparin-Induced ThrombocytopeniaLu Zhou, Andrew Cao, Wen Zhu, et al.
American Journal of Clinical Pathology|February 16, 2010
Clinicopathologic features of agranulocytosis in the setting of levamisole-tainted cocaineDavid R Czuchlewski, Monica Brackney, Christina Ewers, et al.
Thrombosis and Haemostasis|June 3, 2020
Thrombocytopenia and Thromboses in Myocardial Infarction Associated with Eptifibatide-Dependent Activating Antiplatelet AntibodiesRishi V Puram, Rachel M Erdil, Brittany N Weber, et al.
The Lancet. Haematology|April 2, 2025
Rising to the challenge: an international Delphi consensus study on fetal and neonatal alloimmune thrombocytopeniaRomy Pothof, Elske M van den Akker-van Marle, Thijs W de Vos, et al.
Pageof 11

Showing results (91-100 of 107) with videos related to

Sort By:
Pageof 11
Chest|February 25, 2016
A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/ThrombosisAnand Padmanabhan, Curtis G Jones, Brian R Curtis, et al.
Thrombosis and Haemostasis|January 17, 2003
Acute thrombocytopenia in patients treated with the oral glycoprotein IIb/IIIa inhibitors xemilofiban and orbofiban: evidence for an immune etiologyJacqueline A Brassard, Brian R Curtis, Richard A Cooper, et al.
Blood|February 15, 2018
Patients treated with oxaliplatin are at risk for thrombocytopenia caused by multiple drug-dependent antibodiesBrian R Curtis, Yen-Michael S Hsu, Nikolai Podoltsev, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|January 18, 2020
Strategies to develop a prophylaxis for the prevention of HPA-1a immunization and fetal and neonatal alloimmune thrombocytopeniaMette Kjær, Christof Geisen, Çiğdem Akalın Akkök, et al.
Blood|May 20, 2004
Anti-GPVI-associated ITP: an acquired platelet disorder caused by autoantibody-mediated clearance of the GPVI/FcRgamma-chain complex from the human platelet surfaceBrian Boylan, Hong Chen, Vipul Rathore, et al.
JCO Oncology Practice|December 3, 2020
Trastuzumab-Induced Thrombocytopenia Correlated by Drug-Dependent Platelet AntibodiesKathleen Sullivan, Lynne S Kaminer, David L Grinblatt, et al.
Blood|April 21, 2026
PF4/Heparin-Nonbinding Platelet-Activating Antibodies in Heparin-Induced ThrombocytopeniaLu Zhou, Andrew Cao, Wen Zhu, et al.
American Journal of Clinical Pathology|February 16, 2010
Clinicopathologic features of agranulocytosis in the setting of levamisole-tainted cocaineDavid R Czuchlewski, Monica Brackney, Christina Ewers, et al.
Thrombosis and Haemostasis|June 3, 2020
Thrombocytopenia and Thromboses in Myocardial Infarction Associated with Eptifibatide-Dependent Activating Antiplatelet AntibodiesRishi V Puram, Rachel M Erdil, Brittany N Weber, et al.
The Lancet. Haematology|April 2, 2025
Rising to the challenge: an international Delphi consensus study on fetal and neonatal alloimmune thrombocytopeniaRomy Pothof, Elske M van den Akker-van Marle, Thijs W de Vos, et al.
Pageof 11